{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(5)"],"submitter":["Kumar N"],"pubmed_abstract":["<h4>Study design</h4>Retrospective cohort study.<h4>Purpose</h4>To study the incidence, onset, underlying mechanism, clinical course, and factors leading to asymptomatic construct failure (AsCF) after metastatic spinal tumor surgery (MSTS).<h4>Overview of literature</h4>The reported incidence rates for implant and/or construct failure after MSTS are low (1.9%-16%) and based on clinical presentations and revisions required for symptomatic failures (SFs). AsCF after MSTS has not been reported.<h4>Methods</h4>We conducted a retrospective analysis of 288 patients (246 for final analysis) who underwent MSTS between 2005-2015. Data collected were demographics and peri/postoperative clinical and radiological features. Early and late radiological AsCF were defined as presentation before and after "],"journal":["Asian spine journal"],"pagination":["636-649"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8561154"],"repository":["biostudies-literature"],"pubmed_title":["Asymptomatic Construct Failure after Metastatic Spine Tumor Surgery: A New Entity or a Continuum with Symptomatic Failure?"],"pmcid":["PMC8561154"],"pubmed_authors":["Sonawane D","Hey HWD","Patel R","Tan BWL","Pandita N","Lopez KG","Kumar N","Tan JH","Kumar A","Wai KL","Liu G"],"additional_accession":[]},"is_claimable":false,"name":"Asymptomatic Construct Failure after Metastatic Spine Tumor Surgery: A New Entity or a Continuum with Symptomatic Failure?","description":"<h4>Study design</h4>Retrospective cohort study.<h4>Purpose</h4>To study the incidence, onset, underlying mechanism, clinical course, and factors leading to asymptomatic construct failure (AsCF) after metastatic spinal tumor surgery (MSTS).<h4>Overview of literature</h4>The reported incidence rates for implant and/or construct failure after MSTS are low (1.9%-16%) and based on clinical presentations and revisions required for symptomatic failures (SFs). AsCF after MSTS has not been reported.<h4>Methods</h4>We conducted a retrospective analysis of 288 patients (246 for final analysis) who underwent MSTS between 2005-2015. Data collected were demographics and peri/postoperative clinical and radiological features. Early and late radiological AsCF were defined as presentation before and after ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-04T11:16:16.034Z","creation":"2022-02-11T12:48:06.236Z"},"accession":"S-EPMC8561154","cross_references":{"pubmed":["33108848"],"doi":["10.31616/asj.2020.0167"]}}